Workflow Orchestration for siRNA Nucleic Acid Drug Clinical

Data Characteristics for this Category

siRNA nucleic acid drug clinical trial data is multimodal, high-throughput, and dynamic. Data sources are diverse, including gene sequencing reports, proteomics data, metabolomics data, patient electronic health records (EHR), imaging data, and traditional clinical observation indicators. Gene sequencing data typically uses FASTQ, BAM, or VCF formats, containing millions of variant sites. Proteomics data appears in mzML or CSV format, involving expression levels of thousands of proteins. Patient EHRs include unstructured text descriptions, structured diagnostic codes (e.g., ICD-10), and laboratory test results. EHRs update frequently, especially during trials, as patient physiological indicators and adverse event reports are recorded in real-time. Document structures are complex. For example, clinical trial protocol (CTP) documents can be hundreds of pages long, containing detailed inclusion/exclusion criteria, dosing regimens, and evaluation metrics. These documents are usually in PDF format, requiring text extraction and structural processing. Regarding fields and units, gene expression levels are often in FPKM or TPM, protein concentrations in nM or μg/mL, and clinical indicators like blood counts, liver, and kidney function have their own international standard units.

Constraints Imposed by these Characteristics on Workflow Orchestration

The high-throughput nature of siRNA nucleic acid drug data requires workflows to handle large-scale parallel computing, such as gene variant annotation and pathway enrichment analysis. Multimodal data integration necessitates workflow capabilities for heterogeneous data source connection, unifying data from different formats. Dynamically updated patient medical record data demands real-time workflow capabilities, requiring support for incremental updates and event-driven triggers. Pre-processing unstructured documents is critical; OCR or text parsing tools must be integrated to extract and structure key information like inclusion/exclusion criteria and adverse event descriptions from PDFs. This directly impacts subsequent screening logic. For example, determining a patient's specific genotype for enrollment requires extracting information from VCF files and combining it with clinical diagnoses from EHRs, which means the workflow must chain multiple data processing steps. Standardization of fields and units is essential to prevent data parsing errors. The workflow needs explicit configuration for data type conversion and unit calibration steps to ensure data consistency during numerical comparisons and logical judgments.

Configuration Guidelines

Configuration Item	Suggested Value	Rationale for this Value
`maxContext`	`1024 token`	Ensures the model can process gene sequence fragments or key medical record summaries, balancing context length and inference cost.
`PARSE_FILE_TIMEOUT_SECONDS`	`600 seconds`	Provides sufficient processing time for large gene sequencing reports (e.g., VCF files) or multi-page PDF documents.
`Chunk size`	`800–1200 characters`	Accommodates long texts like clinical trial protocols and investigator brochures, ensuring semantic integrity.
`Recall count`	`Top 5 entries`	Prioritizes recalling literature or clinical guideline snippets highly relevant to patient genotype and disease phenotype.
`Similarity threshold`	`0.75`	Filters for clinical trial inclusion/exclusion criteria that best match specific siRNA drug targets or indications.
`Tool Calling Model`	`gpt-4-turbo-2024-04-09`	Complex biological concept understanding and multi-step logical reasoning require stronger model capabilities.

Three Common Pitfalls

During clinical trial screening, core fields (e.g., GeneMutationStatus) are empty, leading to incorrect exclusion or inclusion of some patients. This happens because the data pre-processing stage fails to effectively extract or standardize this field from unstructured medical record text.
The AI dialogue node in the workflow cannot correctly identify the association between specific genotypes and disease phenotypes when processing patient inclusion/exclusion criteria, resulting in inaccurate recommendations. This occurs because the model lacks sufficient siRNA nucleic acid drug-specific domain knowledge during training or fine-tuning.
Large genomics data files upload slowly or return 504 Gateway Timeout errors. This is due to UPLOAD_FILE_MAX_SIZE or PARSE_FILE_TIMEOUT_SECONDS being configured too small, insufficient to handle TB-level data files or complex parsing tasks.

How to Confirm Proper Configuration

Select a batch of patient data with known genotypes, phenotypes, and clinical outcomes. Pre-screen them through the workflow. Verify that the output inclusion/exclusion recommendations align with expectations and evaluate their accuracy.
Integrate data quality check steps into the workflow. For example, validate the format of extracted fields like SNP_ID and Gene_Symbol to ensure data parsing completeness and accuracy.
Simulate inputs of varying data volumes and complexities. Monitor the execution time of each tool node in the workflow to ensure tasks complete within an acceptable timeframe.
Verify that the workflow correctly extracts and applies the latest inclusion/exclusion criteria when processing new or updated clinical trial protocol PDF documents.

Note: The values provided are common starting points and should be measured against the reader's own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.